Analyst firms · Barclays · PHR

Barclays PHR price target and rating history

Phreesia Inc. (PHR) · Consumer Discretionary

Barclays rates Phreesia Inc. (PHR) Equal Weight with a $10 price target, as of its latest action on May 15, 2026. It has published 3 rating actions on PHR since January 2024, including 0 upgrades and 1 downgrade. Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50. Barclays's $10 is 5% below that.

Current rating
Equal Weight
Price target
$10
Median target, all firms
$10.50
Actions on PHR
3

Barclays price target on PHR

$29$20$1020252026
Barclays price target on PHR, each point a stated target, January 2024 to May 2026.

Every Barclays rating on PHR

How other firms rate PHR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Raymond JamesMkt PerformSep 8, 2026
Piper SandlerNeutral$12May 28, 2026
Wells FargoEqual Weight$9May 20, 2026
BarclaysEqual Weight$10May 15, 2026
Citizens JMPMkt PerformApr 1, 2026
Robert W. BairdNeutral$10Mar 31, 2026
Truist SecuritiesHold$11Mar 31, 2026
CitigroupNeutral$10Mar 31, 2026
NeedhamBuy$14Mar 31, 2026
RBC Capital MarketsOutperform$26Jan 9, 2026

Questions about Barclays and PHR

What is Barclays's price target for PHR?
Barclays's latest stated price target for Phreesia Inc. (PHR) is $10, from its action on May 15, 2026.
What is Barclays's rating on PHR?
Barclays rates PHR Equal Weight, a neutral rating, as of May 15, 2026.
When did Barclays last change its view on PHR?
On May 15, 2026, Barclays downgrades to Equal Weight from Overweight, price target $10.
How does Barclays's PHR target compare with other analysts?
Across 8 firms with a PHR price target in the last 12 months, the median target is $10.50. Barclays's $10 is 5% below that.

More PHR rating histories

All Barclays ratingsPHR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.